Manchester Breast Centre (@mcrbreastcentre) 's Twitter Profile
Manchester Breast Centre

@mcrbreastcentre

The goal of the Manchester Breast Centre is to be a world-class centre for basic and translational breast research. Est.2005. Director: @RobClarkeLab

ID: 3825382996

linkhttp://www.breastcentre.manchester.ac.uk calendar_today30-09-2015 15:40:50

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

Journal of Mammary Gland Biology and Neoplasia (@mammary_journal) 's Twitter Profile Photo

👉The review on metastatic #breastcancer #microenvironment by Rob Clarke team is out! It discusses mouse models, ex vivo & 3D in vitro models (#microfluidics & #organonachip), which are paving the way for better drug development & screening. 🔬🧬 link.springer.com/article/10.100…

MFT Research and Innovation (@mft_research) 's Twitter Profile Photo

Professor Gareth Evans, Consultant in Medical Genetics and Cancer Epidemiology, led the team of MFT NHS researchers in the largest study of breast cancer after ovarian cancer diagnosis to date. Read more 👇 research.cmft.nhs.uk/news-events/ma…

Emma Woodward (@er_woodward) 's Twitter Profile Photo

🧬 genetics tells us so much about underlying biology. Thank you to all our families who contribute such vital data that ultimately helps improve outcomes for all 🙏 🧬

UoM Biology, Medicine and Health (@fbmh_uom) 's Twitter Profile Photo

Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from MFT NHS and The University of Manchester has revealed.

Women treated for ovarian cancer caused by an inherited faulty gene have a lower risk of developing breast cancer following that treatment, new research from <a href="/MFTnhs/">MFT NHS</a> and <a href="/OfficialUoM/">The University of Manchester</a> has revealed.
Manchester Cancer Research Centre (@mcrcnews) 's Twitter Profile Photo

📑 Research in Genetics in Medicine shows that women treated for ovarian cancer caused by the BRCA2 gene have a lower risk of developing #BreastCancer for 10 years after follow-up Read more: manchesterbrc.nihr.ac.uk/news-and-event… NIHR Manchester Biomedical Research Centre | Manchester Breast Centre | UoM Biology, Medicine and Health

Breast Cancer Now (@breastcancernow) 's Twitter Profile Photo

It's World Breast Cancer Research Day! Today is a chance to recognise the progress our researchers have made in breast cancer research. So, we wanted to tell you a little more about what our world-class scientists have achieved so far this year 👇

It's World Breast Cancer Research Day! Today is a chance to recognise the progress our researchers have made in breast cancer research.

So, we wanted to tell you a little more about what our world-class scientists have achieved so far this year 👇
Manchester Cancer Research Centre (@mcrcnews) 's Twitter Profile Photo

📑 #ICYMI, research led by Prof. Gareth Evans, funded by NIHR Manchester Biomedical Research Centre and published in Genetics in Medicine shows that women treated for ovarian cancer caused by the BRCA2 gene have a lower risk of developing #BreastCancer for 10 years after follow-up Read more: manchesterbrc.nihr.ac.uk/news-and-event…

METUPUK (@metupukorg) 's Twitter Profile Photo

Please share our infographics, signposted by NHS England and now being implemented across Wales and Scotland #2ndsonthe2nd

Please share our infographics, signposted by NHS England and now being implemented across Wales and Scotland

#2ndsonthe2nd
Rob Clarke (@robclarkelab) 's Twitter Profile Photo

I’ve been enjoying the science at the BA-Breast Cancer Symposium in Argentina and the views at lunchtime are pretty awesome too. Uruguay just over the River Plate. 👀 🇦🇷 🇦🇷 🇦🇷

I’ve been enjoying the science at the BA-Breast Cancer Symposium in Argentina and the views at lunchtime are pretty awesome too. Uruguay just over the River Plate. 👀 🇦🇷 🇦🇷 🇦🇷
David French (@davidfrenchx) 's Twitter Profile Photo

New paper: Development of a breast cancer risk assessment and primary prevention pathway for women aged 30–39 years: Views from primary care providers journals.plos.org/plosone/articl… Dr Sarah Hindmarch Vicky Woof Louise Gorman (she/her) Forms basis for ongoing studies in this area

Dr Lorna McWilliams (@lornamcw) 's Twitter Profile Photo

1/2 Have a read of our latest paper where we interviewed MyPeBS participants about their experiences of risk-stratified breast screening in France and England 👇 tandfonline.com/doi/full/10.10…

Manchester Cancer Research Centre (@mcrcnews) 's Twitter Profile Photo

🚨Applications are open for our MB-PhD scheme! If you're an UoM Biology, Medicine and Health, School of Medicine or UniLeedsMed&Health 💙 undergrad student looking to combine your clinical training with a research PhD, check out our latest opportunities. 👉crukcentre.manchester.ac.uk/opportunity_ca… Deadline: 7 March 2025🗓️

🚨Applications are open for our MB-PhD scheme! 

 If you're an <a href="/FBMH_UoM/">UoM Biology, Medicine and Health</a>, <a href="/StAndMedicine/">School of Medicine</a> or <a href="/LeedsMedHealth/">UniLeedsMed&Health 💙</a> undergrad student looking to combine your clinical training with a research PhD, check out our latest opportunities. 

👉crukcentre.manchester.ac.uk/opportunity_ca…
Deadline: 7 March 2025🗓️
Manchester Cancer Research Centre (@mcrcnews) 's Twitter Profile Photo

Bringing #PostdocAwarenessWeek to an end, we're spotlighting Helen Clarke 🥼 Read more about Helen's PhD on 'Defining the Molecular Impact of Total Dietary Replacement in Endometrial and Breast Tissues' that led her onto her postdoc here in Manchester👇 mcrc.manchester.ac.uk/meet-dr-helen-…

Bringing #PostdocAwarenessWeek to an end, we're spotlighting <a href="/drhelenclarke/">Helen Clarke</a> 🥼

Read more about Helen's PhD on 'Defining the Molecular Impact of Total Dietary Replacement in Endometrial and Breast Tissues' that led her onto her postdoc here in Manchester👇
mcrc.manchester.ac.uk/meet-dr-helen-…